Quest PharmaTech Inc. reported earnings results for the full year ended January 31, 2022. For the full year, the company reported net loss was CAD 85.04 million compared to net income of CAD 190.06 million a year ago. Basic loss per share from continuing operations was CAD 0.505 compared to basic earnings per share from continuing operations of CAD 1.133 a year ago. Diluted loss per share from continuing operations was CAD 0.505 compared to diluted earnings per share from continuing operations of CAD 1.112 a year ago.